Table 3.
Odds Ratios and 95% Confidence Intervals for Associations Between AIDS-Non-Hodgkin Lymphoma and Viral Antibody Index at Various Cutpoints, Adjusted for Age, Sex, Race/Ethnicity, Cohort, and CD4 Count
| Viral antibody index | Controls (n = 67) |
AIDS-NHL cases (n = 66) |
|
|---|---|---|---|
| n (%) | n (%) | OR (95% CI) | |
| ≥4 vs. <4 | 67 (100.0) | 66 (100.0) | — |
| ≥5 vs. <5 | 67 (100.0) | 64 (97.0) | — |
| ≥6 vs. <6 | 66 (98.5) | 63 (95.5) | 0.31 (0.03–3.20) |
| ≥7 vs. <7 | 64 (95.5) | 58 (87.9) | 0.33 (0.08–1.35) |
| ≥8 vs. <8 | 62 (92.5) | 54 (81.8) | 0.33 (0.10–1.07) |
| ≥9 vs. <9 | 61 (91.0) | 48 (72.7) | 0.24 (0.08–0.69) |
| ≥10 vs. <10 | 48 (71.6) | 44 (66.7) | 0.80 (0.37–1.72) |
| ≥11 vs. <11 | 39 (58.2) | 33 (50.0) | 0.73 (0.36–1.47) |
| ≥12 vs. <12 | 28 (41.8) | 24 (36.4) | 0.74 (0.36–1.54) |
| ≥13 vs. <13 | 14 (20.9) | 6 (9.1) | 0.38 (0.14–1.07) |
| ≥14 vs. <14 | 7 (10.5) | 3 (4.6) | 0.41 (0.10–1.71) |
| ≥15 vs. <15 | 4 (6.0) | 1 (1.5) | 0.23 (0.02–2.33) |
| ≥16 vs. <16 | 3 (4.5) | 0 (0.0) | — |
| ≥17 vs. <17 | 2 (3.0) | 0 (0.0) | — |
| ≥18 vs. <18 | 1 (1.5) | 0 (0.0) | — |
Viral antibody index = number of viruses for which an individual is seropositive.